ENANTA PHARMACEUTICALS, INC (ENTA) Operating income 2017–2025
ENANTA PHARMACEUTICALS, INC (ENTA) annual operating income history from SEC filings — each fiscal year as reported.
-$85.3MFY2025 · since FY2017: $24.6M → -$85.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.3M | +29.9% |
| FY2024 | -$121.7M | +11.3% |
| FY2023 | -$137.2M | -10.8% |
| FY2022 | -$123.8M | -13.0% |
| FY2021 | -$109.6M | -163.1% |
| FY2020 | -$41.6M | -213.3% |
| FY2019 | $36.7M | -58.4% |
| FY2018 | $88.3M | +258.9% |
| FY2017 | $24.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENTA financial trends
ENTA RevenueENTA Net incomeENTA Net marginENTA Gross profitENTA Gross marginENTA Operating marginENTA Operating cash flowENTA Free cash flowENTA Capital expendituresENTA Return on equityENTA Stock buybacksENTA Dividends paidENTA Total assetsENTA Total liabilitiesENTA Shareholders’ equityENTA overview →